The effects are varied depending on the particular drug given. When anesthetists administer standard doses of these anesthetic drugs to a person with<unk> , the patient experiences prolonged paralysis of the respiratory muscles, requiring an extended period of time during which the patient must be mechanically ventilated. Eventually the muscle-paralyzing effects of these drugs will wear off despite the deficiency of the<unk>  enzyme. If the patient is maintained on a mechanical respirator until normal breathing function returns, there is little risk of harm to the patient. However, because it is rare in the general population, it is sometimes overlooked when a patient does not wake-up after surgery. If this happens, there are two major complications that can arise. First, the patient may lie awake and paralyzed, while medical providers try to determine the cause of the patient’s unresponsiveness. Second, the breathing tube may be removed before the patient is strong enough to breathe properly, potentially causing respiratory arrest. This enzyme abnormality is a benign condition unless a person with<unk>  is exposed to the offending pharmacological agents. Complications The main complication resulting from<unk>  is the possibility of respiratory failure secondary to succinylcholine or mivacurium-induced neuromuscular paralysis. Individuals with<unk>  also may be at increased risk of toxic reactions, including sudden cardiac death, associated with recreational use of the aromatic ester cocaine.
Pseudocholinesterase deficiency
Cerebral creatine deficiency
Creatine transporter defect
Potassium-aggravated myotonia
Dopamine beta hydroxylase deficiency
Dopamine transporter deficiency syndrome
N-Acetylglutamate synthase deficiency
X-linked myotubular myopathy